Skip to main content

Crohn's Disease News

Related terms: Crohns

Increase in Chronic Digestive Disorders Seen During Pandemic

WEDNESDAY, July 9, 2025 – There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a study recently...

Inflammatory Activity With IBD Tied to Impaired Sleep

WEDNESDAY, July 9, 2025 – Impaired sleep is associated with inflammatory activity in inflammatory bowel disease (IBD), but not symptoms, according to a study published online June 26 in Clinical ...

Fruits And Veggies Protective Against IBD, Study Says

WEDNESDAY, July 9, 2025 — A healthy plant-based diet might protect people from inflammatory bowel diseases, a new study says. People noshing healthy plant-based foods had a 14% lower risk of Crohn’s d...

Common Meds Aren't Linked To Inflammatory Bowel Disease, Study Says

TUESDAY, July 8, 2025 — There’s no evidence that common medications can trigger a chronic inflammatory bowel disease called microscopic colitis, a new study says. Microscopic colitis is responsible fo...

Most TikTok Videos on Inflammatory Bowel Disease Are Low Quality

FRIDAY, June 13, 2025 -- The most-viewed inflammatory bowel disease (IBD) videos on TikTok provide low-quality medical information, according to a study published online in the May/June issue ...

Inflammatory Bowel Disease Info Lacking On TikTok

WEDNESDAY, June 11, 2025 — Many folks with inflammatory bowel disease (IBD) are turning to TikTok for advice, but they aren’t likely to receive useful and accurate information, a new study says. Ana...

FDA Approves Starjemza (ustekinumab-hmny), a Biosimilar to Stelara

Guangzhou and London – May 27, 2025 – Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharm...

Spatiotemporal Mapping IDs Four Stages of Inflammatory Bowel Disease Evolution

TUESDAY, May 6, 2025 – Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD), according to a study published online April 30...

Monthly News Roundup - March 2025

FDA Approves Tremfya for Adults Patients with Active Crohn’s Disease In March, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of Tremfya (guselkumab) for the t...

FDA Approves Tremfya for Active Crohn Disease in Adults

MONDAY, March 24, 2025 – The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease. This approval is the fourth...

Chronic Conditions and Their Age of Onset Predict Health Trajectory in IBD

MONDAY, March 24, 2025 – Among people with inflammatory bowel disease (IBD), conditions developed at or before age 60 years and their age of onset are important for predicting premature death,...

FDA Approves Tremfya (guselkumab) for Adult Patients with Moderately to Severely Active Crohn’s Disease

HORSHAM, Pa. (March 20, 2025) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab), the first and only IL-23 inhibitor o...

IBD Activity May Increase Risk for Clostridioides Difficile Infection

WEDNESDAY, March 5, 2025 – For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage,...

Inflammatory Bowel Disease Tied to Higher Risk for Heart Disease

WEDNESDAY, Feb 5, 2025 – Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study published in the March issue of...

Metrics From Wearable Devices Can Predict IBD Flares

FRIDAY, Jan. 24, 2025 – Physiological metrics from wearable devices can help identify inflammatory bowel disease (IBD) flares, according to a study published online Jan. 16 in Gastroenterology....

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Crohn's Disease - Maintenance, Crohn's Disease - Acute, Inflammatory Bowel Disease

Related drug support groups

Humira, Stelara, Entyvio, Remicade, Skyrizi, cholestyramine, adalimumab, budesonide, ustekinumab, Cimzia